GLAVAHCS, UCLA Department of Medicine, Los Angeles, CA 90073, USA.
Anaerobe. 2012 Apr;18(2):200-8. doi: 10.1016/j.anaerobe.2011.12.017. Epub 2012 Jan 10.
Bacteroides fragilis is a gram-negative anaerobic commensal that can be a virulent pathogen when it escapes its normal niche in the human gut. Recent increases in reports of multi-drug resistance strains of this organism have lent urgency to understanding its mechanisms of antimicrobial resistance. We have identified and characterized RND-type multi-drug efflux pumps in B. fragilis which can pump out a variety of substrates and whose transcription levels can be elevated by a wide variety of antimicrobials, antiseptic agents, bile and other stressors. Our research is directed toward understanding how the efflux pump genes are controlled and how we may exploit that understanding to develop more effective, targeted therapy that will cure the infection without disrupting the entire gut microbiome that is so important in many aspects of human health.
脆弱拟杆菌是一种革兰氏阴性厌氧菌,当它从人类肠道的正常栖息地逃脱时,可能成为一种毒力病原体。最近,有关该生物体多药耐药株的报告增加,这使得人们迫切需要了解其抗微生物耐药机制。我们已经鉴定和表征了脆弱拟杆菌中的 RND 型多药外排泵,该泵可以泵出多种底物,其转录水平可以被多种抗生素、防腐剂、胆汁和其他应激物上调。我们的研究旨在了解外排泵基因是如何被控制的,以及我们如何利用这种理解来开发更有效的靶向治疗方法,在不破坏对人类健康许多方面都非常重要的整个肠道微生物组的情况下治愈感染。